These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 358140)

  • 41. [Dihydroergotoxine mesylate in the treatment of senile cerebral insufficiency. Result of a long-term multicenter double-blind clinical trial with a placebo].
    Lazzari R; Passeri M; Chierichetti SM
    Presse Med; 1983 Dec; 12(48):3179-85. PubMed ID: 6228938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
    Dartigues JF; Père JJ
    Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ergoloid mesylates ('Hydergine') in the treatment of mental deterioration in the elderly: a 6-month double-blind, placebo-controlled trial.
    Rouy JM; Douillon AM; Compan B; Wolmark Y
    Curr Med Res Opin; 1989; 11(6):380-9. PubMed ID: 2651014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydergine in senile mental impairment.
    Loew DM; Weil C
    Gerontology; 1982; 28(1):54-74. PubMed ID: 7037548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amelioration of preservation damage but not cyclosporine nephrotoxicity by dihydroergotoxine in kidney transplant recipients. A double-blind placebo-controlled trial.
    Brouwer ML; Wenting GJ; Vincent HH; Hendriks GF; Jeekel J; Weimar W
    Transplantation; 1989 Nov; 48(5):885-6. PubMed ID: 2815264
    [No Abstract]   [Full Text] [Related]  

  • 46. A dose-response study with dihydroergotoxine mesylate in cerebrovascular disturbances.
    Yoshikawa M; Hirai S; Aizawa T; Kuroiwa Y; Goto F; Sofue I; Toyokura Y; Yamamura H; Iwasaki Y
    J Am Geriatr Soc; 1983 Jan; 31(1):1-7. PubMed ID: 6336765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
    Yesavage JA; Hollister LE; Burian E
    J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical assessment of brain failure in the elderly.
    McConnachie RW
    Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anesthesia of drepanocytic patients (author's transl)].
    Cornen L; Allemand M
    Med Trop (Mars); 1978; 38(2):247-51. PubMed ID: 723572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
    Matejcek M; Knor K; Piguet PV; Weil C
    J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasodilators in senile dementia.
    Maclay WP
    Br Med J; 1979 Oct; 2(6194):866. PubMed ID: 509139
    [No Abstract]   [Full Text] [Related]  

  • 52. A double-blind trial of a phenothiazine compound in the treatment of clinical crisis of sickle cell anaemia.
    Mahmood A
    Br J Haematol; 1969; 16(1):181-4. PubMed ID: 5795208
    [No Abstract]   [Full Text] [Related]  

  • 53. The double-blind assessment of the effect of dihydro ergocryptine on muscle blood flow in normal human volunteer subjects.
    James IM; Burgoyne W
    Br J Clin Pharmacol; 1983 Jan; 15(1):123-5. PubMed ID: 6405769
    [No Abstract]   [Full Text] [Related]  

  • 54. Hydergine in Alzheimer's disease.
    Baer L; Jenike MA
    J Geriatr Psychiatry Neurol; 1991; 4(2):122-3. PubMed ID: 1854422
    [No Abstract]   [Full Text] [Related]  

  • 55. Ergot for dementia?
    Lancet; 1984 Dec; 2(8415):1313-4. PubMed ID: 6150328
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of dihydroergocriptine on mouse and rat resistance to acute anoxia: influence of repetition of treatment.
    Legeai JM; Benharkate MM; Duverger JP; Boulu RG
    Experientia; 1981 Mar; 37(3):292-3. PubMed ID: 6786914
    [No Abstract]   [Full Text] [Related]  

  • 57. Co-dergocrine.
    Krupp P; Loew DM
    Lancet; 1986 Dec; 2(8519):1335. PubMed ID: 2878201
    [No Abstract]   [Full Text] [Related]  

  • 58. Author's Reply-A double-blind case study?
    Liu X; Wu SI
    HeartRhythm Case Rep; 2021 Apr; 7(4):259-260. PubMed ID: 34026509
    [No Abstract]   [Full Text] [Related]  

  • 59. [The action of dihydroergotoxine in acute sickling crisis. Results of a double-blind study carried out in French speaking Africa (author's transl)].
    Begue P; Bertrand E; Bonhomme J; David M; Coullet Y; Pierredon M; Sankale M
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2449-52. PubMed ID: 358140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Double-blind randomised clinical trial of pentoxiphyllin in vaso-occlusive sickle cell crisis.
    Teuscher T; Von Der Ahe CW; Baillod P; Holzer B
    Trop Geogr Med; 1989 Oct; 41(4):320-5. PubMed ID: 2635446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.